Cime Therapeutics

Overview

Defining the Forefront of Automated Chemistry. A chemistry-first company pushing the boundaries of accessible chemical space.

Funding and backers

Total raised
$2.1M
1 round on record
Latest round
$2.1M
Convertible Note · Mar 2025 · 19 mo ago
Team
1-10
employees, estimated range
The money's age
Due for its next round
19 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 14, 2025 Raised a round Convertible Note $2.1M · SEC Form D 2024 Founded
Funding rounds
RoundDateAmountInvestorsSource
Convertible Note Mar 2025 $2.1M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Cime Therapeutics Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
James Brewster IIExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Y Combinator
backs Lumius
Sequoia Capital
backs Iambic Therapeutics
Coatue
backs Iambic Therapeutics
Abstract Ventures
backs Volt
Future Planet Capital
backs Astut Seed
Playground
backs PicoJool
Similar startupsby what they do, their industry and backers
dphnAI
Dolphin is a project dedicated to pushing the boundaries of AI model development and distributed inference.
Astut SeedVenture round · 12 mo ago
Explorative AI Industries Company News Get in touch Astut are pushing the boundaries of Explorative AI in Unprecedented Decision Space…
Lumius
Lumius About Team Join Us About Team Join Us Make ultrasoundubiquitous. We are a startup pushing the boundaries of ultrasound in both…
PicoJoolVenture round $275M · 1 mo ago
PicoJool provides high-performance, energy-efficient data transmission solutions for AI and machine learning applications. Explore how they…
VoltFounded 2018 · 11-50 employees · 2 roles
Our Mission VOLT is building the future of safety - proactive AI protecting people and pushing the boundaries of what's possible. Book a…
Nextmol
Nextmol develops computational chemistry and artificial intelligence solutions for chemical R&D. Discover the platform that L'Oreal and…

Financials

Total raised
$2.1M
Latest round
Convertible Note
Funding rounds
1
Funding rounds
Round Announced Amount
Convertible Note 2025 $2.1M Details

People

James Brewster II
Executive Officer, Director
SEC Form D
Chris Erickson
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Denver United States
HQ
Thank you for your response. ✨
1-10 est. staff
110 16th Street, Denver, CO 80202
company site